🇺🇸 FDA
Patent

US 6753415

23-O-substituted 5-O-mycaminosyltylonide derivatives

expired A61PA61P31/04

Quick answer

US patent 6753415 (23-O-substituted 5-O-mycaminosyltylonide derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P31/04